Stay updated on Tirzepatide in OSA: Clinical Trial

Sign up to get notified when there's something new on the Tirzepatide in OSA: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tirzepatide in OSA: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T16:33:19.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T19:21:58.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 while the study record page remained inaccessible with a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T22:28:44.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:40:24.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden message and a Home link rather than clinical trial information.
    Difference
    0.5%
    Check dated 2026-10-04T22:10:43.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error page, replacing the detailed study content and navigation. This indicates restricted access to the NCT05412004 record on ClinicalTrials.gov.
    Difference
    19%
    Check dated 2026-09-20T22:31:49.000Z thumbnail image

Stay in the know with updates to Tirzepatide in OSA: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tirzepatide in OSA: Clinical Trial page.